SARAH MASCOLO: Open Payments
NPI 1316785165 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,777 in 155 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,214 · 2025 $3,777
Food & beverage: $3,624Education: $153
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $638 |
| Janssen Biotech, Inc. | 26 | $508 |
| Galderma Laboratories, L.P. | 18 | $475 |
| Regeneron Healthcare Solutions, Inc. | 11 | $395 |
| UCB, Inc. | 13 | $361 |
| LEO Pharma Inc. | 17 | $300 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $201 |
| Botanix SB Inc | 2 | $129 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 6 | $111 |
| Organon LLC | 3 | $109 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, Bimzelx, RINVOQ, SKYRIZI, ANZUPGO, ILUMYA.
Industry payments across CT — which companies pay providers there.
